Emtricitabine/Tenofovir disoproxil
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Emtricitabine/Tenofovir disoproxil, covering 2026-06-12 to 2026-06-12. Get the full timeline:
Most recent: EMA Authorised: Emtricitabine/Tenofovir disoproxil Mylan (emtricitabine;tenofovir disoproxil maleate) — Mylan Pharmaceuticals Limited